Skip to main content
. 2021 Jun 7;11(6):1048. doi: 10.3390/diagnostics11061048

Figure 2.

Figure 2

(A) Comparison of total CXCL10 detection using ART or commercial ELISA in ascites fluid from ovarian cancer patients (n = 212). Data is mean +/− SD, triplicate replicates per sample; (B,C) Significant correlations were observed between measurements made using ART or commercial ELISA for both (B) benign (n = 50; p = 0.0371); and (C) malignant (n = 200; p = 0.0002) sample types.